Joseph Catanzaro analyst PIPER SANDLER

Currently out of the existing stock ratings of Joseph Catanzaro, 216 are a BUY (76.87%), 65 are a HOLD (23.13%).

Joseph Catanzaro

Work Performance Price Targets & Ratings Chart

Analyst Joseph Catanzaro works at PIPER SANDLER with a stock forecast success ratio of 36.97% fulfilled within 131.94 days on average.

Joseph Catanzaro’s has documented 541 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on KROS, Keros Therapeutics  at 27-Mar-2024.

Wall Street Analyst Joseph Catanzaro

Analyst best performing recommendations are on CLVS (CLOVIS ONCOLOGY).
The best stock recommendation documented was for CPRX (CATALYST PHARMACEUTICALS) at 11/10/2021. The price target of $7 was fulfilled within 1 day with a profit of $0.55 (8.53%) receiving and performance score of 85.27.

Average potential price target upside

AADI Aadi Bioscience AERI Aerie Pharmaceuticals . CLVS Clovis Oncology CPRX Catalyst Pharmaceuticals CRDF Cardiff Oncology FIGS Figs GBT Global Blood Therapeutics HALO Halozyme Therapeutics IMGN ImmunoGen IMMU Immunomedics IOVA Iovance Biotherapeutics LPTX Leap Therapeutics NCNA NuCana PLC NLTX Neoleukin Therapeutics OCUL Ocular Therapeutix RAIN Rain Therapeutics SGEN Seagen CTMX CytomX Therapeutics EPIX ESSA Pharma HARP Harpoon Therapeutics IMAB I-Mab MRKR Marker Therapeutics RPTX Repare Therapeutics BMEA Biomea Fusion CNTB Connect Biopharma Holdings Ltd DAWN Day One Biopharmaceuticals GRCL Gracell Biotechnologies . IBRX Immunitybio SNSE Sensei Biotherapeutics KROS Keros Therapeutics  NRIX Nurix Therapeutics  OYST Oyster Point Pharma STML Stemline Therapeutics ACHL Achilles Therapeutics PLC ADR GILD Gilead Sciences

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

5

$3.22 (180.90%)

30

4 months 11 days ago

0/5 (0%)

$2.66 (113.68%)

Hold

4 months 11 days ago

0/4 (0%)

$31.56 (191.97%)

Buy

4 months 11 days ago

0/1 (0%)

$20.97 (87.27%)

Buy

2 years 15 days ago

2/2 (100%)

$4.5 (25.00%)

82

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Joseph Catanzaro is most bullish on?

Potential upside of $48.76 has been obtained for KROS (KEROS THERAPEUTICS )

Which stock is Joseph Catanzaro is most reserved on?

Potential downside of -$7.23 has been obtained for IMGN (IMMUNOGEN)

What Year was the first public recommendation made by Joseph Catanzaro?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?